Relapse Patterns in Chronic Hep B After Halting Treatment
(MedPage Today) -- Chronic hepatitis B patients who discontinued tenofovir disoproxil fumarate (TDF, Viread) after achieving viral suppression had higher rates of clinical relapse compared to those who stopped entecavir, a global retrospective... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 21, 2022 Category: Gastroenterology Source Type: news
Laparoscopy Noninferior to Open Surgery in Locally Advanced Gastric Cancer
(MedPage Today) -- Five-year follow-up results from the KLASS-02 randomized trial confirmed that laparoscopic surgery is not inferior to open gastrectomy in patients with locally advanced gastric cancer.
At a median follow-up of 69.4 months, 5... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 20, 2022 Category: Gastroenterology Source Type: news
What's the Safest Path to Neoadjuvant Therapy in Liver Cancer?
(MedPage Today) -- Immune checkpoint inhibitors (ICIs) had a more favorable safety profile for advanced liver cancer than did tyrosine kinase inhibitors (TKIs), according to a clinical trial meta-analysis.
In a pooled analysis of 30 studies, ICIs... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 18, 2022 Category: Gastroenterology Source Type: news
Novel Antifibrotic Improved Fibrosis in Chronic Hepatitis B
(MedPage Today) -- Investigational hydronidone, when added to entecavir (Baraclude), reduced liver fibrosis for chronic hepatitis B patients, a phase II trial in China found.
In an intention-to-treat analysis of 168 such patients, the direct-acting... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 15, 2022 Category: Gastroenterology Source Type: news
CMS Plan to Cover Follow-Up Colonoscopy; Second Go for Ocaliva in NASH; Drusen & IBD
(MedPage Today) -- The Centers for Medicare & Medicaid Services (CMS) announced plans to cover follow-up colonoscopy following a positive at-home fecal test.
Intercept Pharmaceuticals said it will again seek an indication for obeticholic acid... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 14, 2022 Category: Gastroenterology Source Type: news
